摘要
目的评价辛伐他汀及联用阿司匹林对扩张型心肌病患者栓塞事件及死亡率的影响。方法将27例扩张型心肌病患者分为辛伐他汀及联用阿司匹林组27例和对照组26例,追踪观察两组的栓塞事件发生率、死亡率及总有效率。结果辛伐他汀及联用阿司匹林组栓塞事件发生率明显低于对照组(P<0.05);两组治疗总有效率及死亡率相比差异无统计学意义(P>0.05)。治疗前、后未发现皮肤黏膜淤斑及内脏出血情况、过敏反应等不良反应。结论扩张型心肌病患者应用应用辛伐他汀及联用阿司匹林抗血小板治疗,可降低患者的栓塞事件发生,但并不增加患者治疗总有效率及减少死亡率。
Objective To evalue the effect of Simvastatin and aspirin in patients with dilating cardiomyopathy embolization incident and impact of mortality. Methods 53 cases of patients with dilated cardiomyopathy were divided into group aspirin and simvastatin 27 of and control 26 patients. Two groups observed the incident thrombosis rate, mortality and total efficiency. Results Incident rate of group Simvastatin and aspirin was significantly lower than that of control (P < 0.05). No significant difference was sho...
出处
《中外医疗》
2008年第21期22-23,共2页
China & Foreign Medical Treatment
